Weight Changes in Parkinsonian Patients, Treated With Deep Brain Stimulation
NCT ID: NCT00221793
Last Updated: 2008-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2002-12-31
2006-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Twenty parkinsonian patients will be randomised : the delay between inclusion and neurostimulation wil be lengthened 3 months for one group, compared to the second one. The energy expenditure, at rest and after ingestion of a test meal, will be compared between the group of patients that had been neurostimulated and the group whose intervention has been postponed. Weight changes, energy intake, leptin level, neurophysiological parameters will be compared between both groups, and the nature and repartition of the weight gain will be assessed in the neurostimulated group. An eventual link between motor factors, pharmacological factors, and gain weight will be studied.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Deep Brain Stimulation of the Subthalamic Nucleus
Deep brain stimulation
Brain Stimulation of the Subthalamic Nucleus
2
Later Deep Brain Stimulation of the Subthalamic Nucleus
Deep brain stimulation
Brain Stimulation of the Subthalamic Nucleus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Deep brain stimulation
Brain Stimulation of the Subthalamic Nucleus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
35 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University Hospital, Bordeaux
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François TISON, Pr
Role: PRINCIPAL_INVESTIGATOR
Service de neurologie Hôpital Haut-Lévêque Pessac
Jacques DEMOTES-MAINARD, Pr
Role: STUDY_CHAIR
CIC Inserm-CHU de Bordeaux Pessac
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de neurologie Hôpital Haut-Lévêque
Pessac, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9212-02
Identifier Type: -
Identifier Source: org_study_id